1[1]Lee JA, Allen DG. Calcium sensitisers: mechanisms of action and potential usefulness as inotropes[J]. Cardiovasc Res,1997,36:10～20.
2[2]Haikala H, Nissinen E, Etemadzadeh E,et al. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation[J]. J Cardiovasc Pharmacol,1995,25:794～801.
3[3]Jamali,Iyad N . Intracoronary Levosimnndan ehances contractile function of stunned myocardium[J]. Anesth Analg,1997,85:23～29.
4[4]Wendt IR, Stephenson DG. Effects of caffeine on Ca-activated force production in skinned cardiac and skeletal muscle fibers of the rat[J]. Pflugers Arch,1983,398:210～216.
5[5]Li G, Martin AF, Solaro RJ. Localization of regions of troponin I important in deactivation of cardiac myofilaments by acidic pH[J]. J Mol Cell Cardiol,2001,33:1309～1320.
6[6]Haikala H, Kaivola J, Nissinen E, et al. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan[J]. J Mol Cell Cardiol,1995,27:1859～1866.
7[7]Hasenfuss G, Pieske B, Castell M, et al. Influence ofthe novel inotropic agent levosimendan on isometric tension and calcium cyclingin failing human myocardium[J]. Circulation,1998,98:2141～2147.
8[8]Yokoshiki H, Katsube Y, Sunagawa M, et al. Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes[J]. Eur J Pharmacol,1997,333:249～259.
9[9]Du Toit EF, Muller CA, McCarthy J, et al. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart[J]. J Pharmacol Exp Ther,1999,290:505～514.
10[10]Bolli R.mechanism of myocardia"stunning"[J].Circulation,1990,82(2):732～738.
